Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenomics of Prednisone Response in Healthy Volunteers
NCT03023891Phase 1Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Feb 2017
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of prednisone in Inflammatory Disorders, sponsored by Vanderbilt University Medical Center. Primary endpoints: White Blood Cell Counts at 8 hours, Area Under the Curve for Plasma Glucose and 2 more. Started Feb 2017; status: completed.
02
Drugs
prednisone
03
Conditions
Inflammatory Disorders
Beyond the preview
Go deeper on NCT03023891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03023891.